Author

Maddalena T. Tilli

Observed names: M T Tilli, MADDALENA T. TILLI, Maddalena T Tilli, Maddalena Tilli, Maddalena Tilli Shiffert, Tilli, Maddalena T

Observed institutions: University of Maryland, Baltimore, National Institutes of Health, McDaniel College, Georgetown University, Georgetown University Medical Center, National Human Genome Research Institute, Dankook University Hospital, Georgetown Lombardi Comprehensive Cancer Center, Dankook University

OpenAlex ID: A5073725946

The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2008 · Mark P. Fereshteh, Maddalena T. Tilli, et al. · Cancer Research · 97

Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ.

2005 · M Silvina Frech, Ewa D Halama, et al. · PubMed · 92

EXPLANT-CELL CULTURE OF PRIMARY MAMMARY TUMORS FROM MMTV-c-Myc TRANSGENIC MICE

2004 · XU FANG PEI, MARCIA S. NOBLE, et al. · In Vitro Cellular & Developmental Biology - Animal · 90

Deregulated Estrogen Receptor α Expression in Mammary Epithelial Cells of Transgenic Mice Results in the Development of Ductal Carcinoma In situ

2005 · M. Silvina Frech, Ewa D. Halama, et al. · Cancer Research · 83

Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer

2007 · L P Jones, M T Tilli, et al. · Oncogene · 65

Overexpression of an N-Terminally Truncated Isoform of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 Leads to Altered Proliferation of Mammary Epithelial Cells in Transgenic Mice

2004 · Maddalena T. Tilli, Ronald Reiter, et al. · Molecular Endocrinology · 52

Introduction of Estrogen Receptor-α into the tTA/TAg Conditional Mouse Model Precipitates the Development of Estrogen-Responsive Mammary Adenocarcinoma

2003 · Maddalena T. Tilli, M. Silvina Frech, et al. · American Journal Of Pathology · 52

Real-time imaging and characterization of human breast tissue by reflectance confocal microscopy

2007 · Maddalena T. Tilli, Marina C. Cabrera, et al. · Journal of Biomedical Optics · 49

Conditional Over-Expression of Estrogen Receptor Alpha in a Transgenic Mouse Model

2002 · Kathleen S. Hruska, Maddalena T. Tilli, et al. · Transgenic Research · 31

Altered AIB1 or AIB1Δ3 Expression Impacts ERα Effects on Mammary Gland Stromal and Epithelial Content

2011 · Rebecca E. Nakles, Maddalena Tilli Shiffert, et al. · Molecular Endocrinology · 22

Functional mimicry of the acetylated C‐terminal tail of p53 by a SUMO‐1 acetylated domain, SAD

2010 · Amrita Cheema, Chad D. Knights, et al. · Journal of Cellular Physiology · 20

Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer

2005 · Angela Parrish, Ewa Halama, et al. · Journal of Biomedical Optics · 17

Comparison of mouse mammary gland imaging techniques and applications: Reflectance confocal microscopy, GFP Imaging, and ultrasound

2008 · Maddalena T Tilli, Angela R Parrish, et al. · BMC Cancer · 16

Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence

2003 · Maddalena T Tilli, Priscilla A Furth · Breast Cancer Research · 13

Loss of protein phosphatase 2A expression correlates with phosphorylation of DP-1 and reversal of dysplasia through differentiation in a conditional mouse model of cancer progression.

2003 · Maddalena T Tilli, Shawnté L Hudgins, et al. · PubMed · 11

Survey of genetic counselors and clinical geneticists regarding recurrence risks for families with nonsyndromic cleft lip with or without cleft palate

1998 · Diego F. Wyszynski, Joanna Zeiger, et al. · American Journal of Medical Genetics · 11

Chemoprevention of mammary carcinogenesis in a transgenic mouse model by α-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity

2003 · M Li, S Ren, et al. · Oncogene · 8

Supplementary Methods, Figure Legends 1-2 from The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2023 · Mark P. Fereshteh, Maddalena T. Tilli, et al.

Supplementary Figure 2 from The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2023 · Mark P. Fereshteh, Maddalena T. Tilli, et al.

Supplementary Figure 1 from The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2023 · Mark P. Fereshteh, Maddalena T. Tilli, et al.

Supplementary Figure 1 from The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2023 · Mark P. Fereshteh, Maddalena T. Tilli, et al.

Supplementary Methods, Figure Legends 1-2 from The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2023 · Mark P. Fereshteh, Maddalena T. Tilli, et al.

Supplementary Figure 2 from The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2023 · Mark P. Fereshteh, Maddalena T. Tilli, et al.

Data from The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2023 · Mark P. Fereshteh, Maddalena T. Tilli, et al.

Data from The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

2023 · Mark P. Fereshteh, Maddalena T. Tilli, et al.

Works count: 38

Citation count: 729

H-index: 13

I10-index: 16